R&D Breaking into the global pharmaceutical market In 2022, pharma is truly a global industry, and innovation can come from anywhere.
News Digital health accelerator Pulse launches in Boston Selected start-ups will receive part of a $250,000 pot.
News EU clears first drug therapy for rare disease cALD Neuraxpharm and Minoryx' Nezglyal has become the first approved drug therapy in the EU for rare neurodegenerative disease cALD.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
